Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rollins

Showing results (191-200 of 214) with videos related to

Pageof 22
Sort By:
Blood|May 16, 2009
RhoA and Rac1 GTPases play major and differential roles in stromal cell-derived factor-1-induced cell adhesion and chemotaxis in multiple myelomaAbdel Kareem Azab, Feda Azab, Simona Blotta, et al.
Blood|April 30, 2009
MicroRNAs 15a and 16 regulate tumor proliferation in multiple myelomaAldo M Roccaro, Antonio Sacco, Brian Thompson, et al.
Blood|December 17, 2008
microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemiaAldo M Roccaro, Antonio Sacco, Changzhong Chen, et al.
Blood|June 4, 2010
Recurrent BRAF mutations in Langerhans cell histiocytosisGayane Badalian-Very, Jo-Anne Vergilio, Barbara A Degar, et al.
Msystems|March 23, 2022
High-Content Screening and Computational Prediction Reveal Viral Genes That Suppress the Innate Immune ResponseTai L Ng, Erika J Olson, Tae Yeon Yoo, et al.
Blood|January 14, 2009
CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapyAbdel Kareem Azab, Judith M Runnels, Costas Pitsillides, et al.
Clinical Toxicology (Philadelphia, Pa.)|June 11, 2015
Methodology for AACT evidence-based recommendations on the use of intravenous lipid emulsion therapy in poisoningSophie Gosselin, Martin Morris, Andrea Miller-Nesbitt, et al.
Blood|March 12, 2016
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineagesJean-François Emile, Oussama Abla, Sylvie Fraitag, et al.
NPJ Precision Oncology|October 6, 2022
MatchMiner: an open-source platform for cancer precision medicineHarry Klein, Tali Mazor, Ethan Siegel, et al.
The Journal of Molecular Diagnostics : JMD|August 27, 2014
Prospective enterprise-level molecular genotyping of a cohort of cancer patientsLaura E MacConaill, Elizabeth Garcia, Priyanka Shivdasani, et al.
Pageof 22

Showing results (191-200 of 214) with videos related to

Sort By:
Pageof 22
Blood|May 16, 2009
RhoA and Rac1 GTPases play major and differential roles in stromal cell-derived factor-1-induced cell adhesion and chemotaxis in multiple myelomaAbdel Kareem Azab, Feda Azab, Simona Blotta, et al.
Blood|April 30, 2009
MicroRNAs 15a and 16 regulate tumor proliferation in multiple myelomaAldo M Roccaro, Antonio Sacco, Brian Thompson, et al.
Blood|December 17, 2008
microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemiaAldo M Roccaro, Antonio Sacco, Changzhong Chen, et al.
Blood|June 4, 2010
Recurrent BRAF mutations in Langerhans cell histiocytosisGayane Badalian-Very, Jo-Anne Vergilio, Barbara A Degar, et al.
Msystems|March 23, 2022
High-Content Screening and Computational Prediction Reveal Viral Genes That Suppress the Innate Immune ResponseTai L Ng, Erika J Olson, Tae Yeon Yoo, et al.
Blood|January 14, 2009
CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapyAbdel Kareem Azab, Judith M Runnels, Costas Pitsillides, et al.
Clinical Toxicology (Philadelphia, Pa.)|June 11, 2015
Methodology for AACT evidence-based recommendations on the use of intravenous lipid emulsion therapy in poisoningSophie Gosselin, Martin Morris, Andrea Miller-Nesbitt, et al.
Blood|March 12, 2016
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineagesJean-François Emile, Oussama Abla, Sylvie Fraitag, et al.
NPJ Precision Oncology|October 6, 2022
MatchMiner: an open-source platform for cancer precision medicineHarry Klein, Tali Mazor, Ethan Siegel, et al.
The Journal of Molecular Diagnostics : JMD|August 27, 2014
Prospective enterprise-level molecular genotyping of a cohort of cancer patientsLaura E MacConaill, Elizabeth Garcia, Priyanka Shivdasani, et al.
Pageof 22